medigraphic.com
Boletín Clínico de la Asociación Médica del Hospital Infantil del Estado de Sonora

2010, Number 1

<< Back Next >>

Bol Clin Hosp Infant Edo Son 2010; 27 (1)

Eritema Infeccioso o Quinta Enfermedad

Reyes-Gómez U, Ramírez-Ponce B, Reyes-Hernández U, Reyes-Hernández D, Alonso-Rivera C, Rentería-Cárdenas A

Language: Spanish
References: 27
Page: 56-60
PDF size: 242.97 Kb.


ABSTRACT

The present is a current review on parvovirus B19, viral disease known in its most common manifestation as erythema infectiosum or fifth disease.
It occurs most frequently in children and even though this was described 1985, its diagnosis is rarely documented. Usually this disease is commonplace, but immunocompromised patients can lead to multiple complications including chronic anemia, arthritis, leucopenia hemophagocytosis, if present in women before 20 weeks of pregnancy, may cause fetal death or hydrops. Some considerations are made for early clinical diagnosis and review of important concepts of the literature.


REFERENCES

  1. Guzmán M, Rosario D, Rodríguez M. Diagnóstico virológico de un brote de fiebre y rash producido por Parvovirus B19, Cuba, 1995. Rev Cubana Med Trop 1997; 49: 1-4

  2. Scharre JE, Veith J. Conjunctivitis associated with fifth disease in a child: a case report. J. Am. Optom. Assoc. 1996; 67: 763-6.

  3. Hedrick J. The effects of human parvovirus B19 and cytomegalovirus during pregnancy. J. Perinat. Neonatal. Nurs. 1996; 10(2): 30-9.

  4. Reid DM, Reid TMS, Brown T. Human parvovirus associated arthritis: A clinical and laboratory description. Lancet 1985; 1: 422.

  5. Cassinotti P, Siegl G. Quantitative evidence for persistence of human parvovirus B19 DNA in an immunocompetent individual. Eur J Clin Microbiol Infect Dis 2000; 19:866-7.

  6. Cubel RCN, Oliveira SA, Brown DWG, Cohen BJ, Nascimento JP. Diagnosis of parvovirus B19 infection by detection of specific immunoglobulin M antibody in saliva. J Clin Microbiol 1996; 34:205-7.

  7. Show-Mei KK et al. Color atlas & synopsis of pediatric dermatology. McGraw-Hill; USA: 2002.p.578-9.

  8. Mancebo HA, González RA, González S, Lombardo AE. Estudio de un brote de infección por parvovirus B19 en un hospital de la Ciudad de México. Acta Pediatr Mex 2006; 27(2): 66-72.

  9. Red book 2003. Informe del comité de enfermedades infecciosas 26ª ed. American Academy of Pediatrics 2000: 535-6.

  10. Sherwood WC. The significance of the blood-borne viruses: blood banking and transfusion medicine. Dev Biol Stand. 1993; 81: 25-33

  11. Brown KE. Young NS. Parvovirus B19 in human disease. Annu Rev Med. 1997; 48: 59-67.

  12. Zamora CHA, Rodríguez RS, Gómez BD. Escarlatina Rev. Mex. Puer. Ped. de Mex. 1996; 4: 19-27.

  13. Zamora CHA, Rodríguez RS, Gómez BD. Eritema infeccioso Rev. Mex. Puer. Ped. de Mex. 1996: 3: 153-5.

  14. Reyes GU. Carbajal RL. Velasco MA. López CG. Perez GJ. Díaz AA. Trastornos del ritmo cardiaco por parvovirus B19, reporte de caso. Rev. Mex. Puer Ped. 2000; 42 (7): 184-8.

  15. Servey JT, et al. Clinical presentations of parvovirus B19 infection. Am Fam Physician. 2007; 75: 373-6.

  16. Broliden K, et al. Clinical aspects of parvovirus B19 infection. J Intern Med 2006; 260: 285-304.

  17. Rentería CA. Eritema infeccioso en: Martínez MR. (editor). La salud del niño y del adolescente sexta edición editorial el manual moderno: México; 2009 .p.725.

  18. Rodríguez RS. Lupus Eritematoso Sistémico en: Rodríguez RS (editor) Reumatología Pediátrica Interamericana: México; 1994 p.135.

  19. Chinea B, Ramírez RCH. Infections caused by parvovirus B19. Bol Asoc Med P R. 1996; 88(1-3): 20-6.

  20. Luban NL. Human parvoviruses: implications for transfusion medicine [see comments].Transfusion. 1994; 34(9): 821-7.

  21. Brown KE. Young NS. Liu JM. Molecular, cellular and clinical aspects of parvovirus B19 infection. Crit Rev Oncol Hematol 1994; 16(1): 1-31.

  22. Setubal S, et al. Clinical presentation of parvovirus B19 infection in HIV-infected patients with and without AIDS. Rev Soc Bras Med Trop 2003; 36:299-302.

  23. Heegaard Ed, et al. Human parvovirus B19. Clin Microbiol Rev 2002; 15:485-505.

  24. Hedrick J. The effects of human parvovirus B19 and cytomegalovirus during pregnancy. J. Perinat. Neonatal. Nurs. 1996; 10(2): 30-9.

  25. Reyes GU, Rentería CA, Ochoa GM. Gammaglobulina intravenosa: Actuales y posibles nuevas indicaciones Práctica Pediátrica. 1997; 6: 7-12.

  26. Reyes GU. Eritema infeccioso 5ª.enfermedad en: Rentería CA. (editor): Prontuario de infectologia Pediátrica 2ª edición. Facultad de Medicina Universidad Autónoma de San Luis Potosí; 2010.

  27. Gutiérrez G. Eritema Infeccioso (quinta enfermedad) en: Kumate J, Gutierrez G. Manual de infectología 8ª edición México: editorial Méndez Cervantes; 1981.p.286-91.




2020     |     www.medigraphic.com